Biopharma Science Blogs | Technology Networks

Industry Insights

Real-time Antibody Titer Monitoring Advances Bioprocessing Capabilities

Industry Insight

In facilitating the move to continuous processing in biotherapeutic production, bioprocessing specialists are being driven to develop innovative analytical testing methods for key measurements of output and quality, such as antibody titer.

The Startup Turning Yeast Into Psychedelics

Industry Insight

Technology Networks recently spoke with Nick Milne, co-founder and CSO at Octarine to learn more about what science says on the therapeutic benefits of psychedelic compounds, why a bio-based approach for manufacturing is advantageous and the challenges associated.

Finding the Best Cells for Faster Drug Discovery

Industry Insight

Advances in developing cell-based therapeutics and products require time-consuming and laborious cell-by-cell manipulation and analysis. Berkeley Lights Inc provide research and development services to help accelerate this process and make it more efficient via their proprietary technology. Technology Networks recently spoke with Mark White, Sr. Director of Marketing, Berkeley Lights Inc to find out more.

Exploring the Potential of Antibody–Drug Conjugates

Industry Insight

The UK registered and self-funding charity LifeArc has several antibody–drug conjugate (ADC) programs in the oncology and non-oncology space. Technology Networks recently had the pleasure of speaking with Dr Laura Murch, Scientist at LifeArc, to learn more about ADCs. She highlights some of the antibody characterization assays they have developed to identify candidate ADCs, and touches on the regulatory success of ADCs.

Developing the World's First Single Molecule Protein Sequencer

Industry Insight

Jagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.

Innovative Spectroscopy Is Enhancing Protein Structure Determination

Industry Insight

Proteins are central to many disciplines within the life sciences, not least protein-based pharmaceuticals. Changes in protein conformation, structure or interactions could have significant impact on efficacy and safety. Therefore, being able to understand what forms of a protein are present in their natural conditions, even if present only at low levels, is important for analysts.

The Global Impact of COVID-19 on Clinical Trials and the Way Forward

Industry Insight

While the healthcare community has rallied together in efforts to develop therapeutics and vaccines for COVID-19, we must not forget the other trials underway and those in the R&D pipeline that will also help conquer disease. There is an urgent need to use advanced and innovative approaches to ensure the continuity of existing trials and the start of new studies.

Tackling the COVID-19 Pandemic – Why Collaboration and Communication Are Crucial

Industry Insight

In this interview we focus on Research-Aid Networks' activities in relation to the COVID-19 pandemic. Research-Aid Networks' Matthew Badham, highlights the importance of collaboration and communication in these unprecedented times, discusses what we currently know about the novel coronavirus (SARS-CoV-2) and elaborates on the analysis RAN has been conducting.

Consortium Members Work To Deliver UK's First COVID-19 Vaccine As Quickly and Safely As Possible

Industry Insight

A consortium led by the Jenner Institute at Oxford University is working to rapidly develop, scale-up and manufacture the potential COVID-19 vaccine, ChAdOx1 nCov-19, or ChAdOx1, for fast-tracked clinical trials. Technology Networks spoke with Tony Hitchcock, Technical Director at Cobra Biologics to find out more about the consortium's aims, how the vaccine works and to gain insights on realistic timelines for vaccine development and manufacturing.